What's The Job Market For ADHD Medication Pregnancy Professionals Like? > 자유게시판

• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

ADHD Medication During Pregnancy and Breastfeeding

The decision to stop or continue ADHD medications during pregnancy and breastfeeding is a challenge for women suffering from the condition. There aren't many studies regarding how exposure over time may affect a pregnant fetus.

A study recently published in Molecular Psychiatry demonstrates that children exposed to ADHD medication during pregnancy do not develop neurological disorders such as hearing loss or vision, febrile seizures, or IQ impairment. The authors acknowledge the need for higher-quality studies.

Risk/Benefit Analysis

Women who are expecting and taking ADHD medication need to evaluate the benefits of using it against the possible risks to the fetus. Physicians don't have the information needed to provide clear recommendations however they can provide information about risks and benefits that help pregnant women make informed choices.

A study published in Molecular Psychiatry concluded that women who were taking ADHD medication during early pregnancy did not have a greater risk of fetal malformations or structural birth defects. Researchers conducted a large population-based case control study to assess the frequency of structural defects that were major in infants who were born to mothers who took stimulants during pregnancy. Clinical geneticists, pediatric cardiologists and other experts examined the cases to make sure that the classification was accurate and to minimize any bias.

The study conducted by the researchers had some limitations. Researchers were unable, in the first place to differentiate the effects caused by the medication from the disorder. This limitation makes it difficult to determine whether the small differences observed in the exposed groups result from medication use or confounding by comorbidities. Additionally the researchers did not study the long-term effects of offspring on their parents.

The study did reveal that infants whose mothers had taken ADHD medications during pregnancy were at slightly greater risk of being admitted to the neonatal intensive care unit (NICU) than those whose mothers had not taken any medication or had taken off their medication prior to or during pregnancy. This increase was caused by central nervous system disorders. The higher risk of admission was not affected by the stimulant medications used during pregnancy.

Women who took stimulant adhd medication without diagnosis uk medications during pregnancy also had a higher risk of having to have an emergency caesarean section or having a baby that scored low on the Apgar scale (less than 7). These increases appeared to be unrelated to the type of medication taken during pregnancy.

Researchers suggest that the minor risk of using adhd Medication pregnancy medication during pregnancies in the early stages can be offset by more beneficial outcomes for both mother and baby from continuing treatment for the woman's disorder. Physicians should speak with their patients about this issue and as much as possible, assist them develop coping strategies that could reduce the effects of her disorder on her daily life and relationships.

Interactions with Medication

As more women than ever before are being diagnosed with ADHD and treated with medication, the dilemma of whether or not to stop treatment during pregnancy is a question that more and more doctors confront. The majority of these decisions are made in the absence of any evidence that is clear and definitive either way, so physicians have to weigh their experience, the experiences of other doctors, and what research suggests on the subject and their own best adhd medication for women judgment for each individual patient.

In particular, the issue of potential risks for the infant can be difficult. The research that has been conducted on this topic is based on observation rather than controlled studies and the results are in conflict. Furthermore, most studies restrict their analysis to live births, which may underestimate severe teratogenic effects that cause abortion or termination of the pregnancy. The study discussed in this journal club addresses these issues by analyzing data on live and deceased births.

The conclusion: While some studies have found an association between ADHD medications and the possibility of certain birth defects, others have not found any evidence of a link, and most studies have a neutral or slightly negative impact. In the end, a careful risk/benefit assessment is required in every instance.

It can be challenging, if not impossible, for women suffering from ADHD to stop taking their medication. In fact, in a recent article in the Archives of Women's Mental Health, psychologist Jennifer Russell notes that stopping ADHD medication during pregnancy can increase depression, feelings of loneliness, and family conflict for those suffering from the disorder. The loss of medication can also impact the ability to drive safely and to perform work-related tasks which are vital aspects of daily life for those with ADHD.

She suggests that women who aren't sure whether to continue taking the medication or stop due to pregnancy educate family members, coworkers and acquaintances about the condition, its impact on daily functioning and the benefits of keeping the current treatment. It can also help a woman feel more confident in her decision. Some medications can pass through the placenta. If a patient decides to not take her ADHD medication while pregnant and breastfeeding, it is crucial to be aware that the medication could be passed on to her infant.

Risk of Birth Defects

As the use of adhd anxiety medication drugs to treat symptoms of attention deficit hyperactivity disorder (ADHD) grows as do concerns about what impact the medications could have on fetuses. A recent study published in the journal Molecular Psychiatry adds to the body of knowledge on this subject. Utilizing two huge data sets, researchers were able to analyze more than 4.3 million pregnancies to determine whether the use of stimulant medications increased the risk of birth defects. Although the risk overall remains low, the scientists found that exposure in the first trimester to ADHD medications was associated with an increased risk of certain heart defects, such as ventriculoseptal defect (VSD).

The authors of the study found no connection between early use of medication and other congenital abnormalities, such as facial clefting or club foot. The results are in line with previous studies that have shown the presence of a small, but significant increase in the risk of heart malformations among women who began taking ADHD medications before pregnancy. The risk increased in the latter stages of pregnancy when many women stopped taking their medication.

Women who used ADHD medications in the first trimester of their pregnancies were also more likely to have caesarean section, low Apgar score following delivery, and a baby that required breathing assistance during birth. However the authors of the study were unable to eliminate selection bias by restricting the study to women who did not have other medical issues that could have contributed to the findings.

The researchers hope their research will aid in the clinical decisions of physicians who see pregnant women. They advise that while discussing the risks and benefits is crucial however, the decision to stop or continue medication should be based on the woman's needs and the severity of her ADHD symptoms.

The authors also warn that, while stopping the medication is an option, it isn't a recommended practice because of the high prevalence of depression and other mental health problems in women who are pregnant or post-partum. Further, research shows that women who stop taking their medication will have a tough adjustment to life without them after the baby is born.

Nursing

It can be a challenge to become a mom. Women who suffer from ADHD who have to deal with their symptoms while attending doctor appointments as well as preparing for the arrival of a child and adjusting to new household routines may face a lot of challenges. This is why many women decide to continue taking their ADHD medication throughout the pregnancy.

The majority of stimulant medicines are absorbed by breast milk in small amounts, therefore the risk for infant who is breastfeeding is low. However, the rate of medication exposure to the newborn may differ based on the dosage, frequency it is administered and the time of the day it is administered. Additionally, individual medications enter the body of the baby differently through the gastrointestinal tract as well as breast milk, and the effect of this on a newborn is not well known.

Some doctors may decide to stop stimulant medication during a woman's pregnancy due to the lack of research. It's a difficult choice for the woman, who must weigh the benefits of taking her medication as well as the risk to the fetus. In the meantime, until more information is available, doctors should ask all pregnant patients about their experience with ADHD and if they plan or are taking to take medication during the perinatal period.

Numerous studies have proven that women can continue to take their ADHD medication in a safe manner while breastfeeding and during pregnancy. In response, an increasing number of patients are adhd meds covered by ohip opting to do this. They have discovered through consultation with their doctors that the benefits of keeping their current medication outweigh any risk.

Women with ADHD who are planning to nurse should seek advice from a specialist psychiatrist before becoming pregnant. They should review their medications with their physician and discuss the pros and cons of continued treatment, including non-pharmacological strategies. Psychoeducation should also be provided to help pregnant people with ADHD recognize their symptoms and the underlying disorder, learn about available treatment options and strengthen existing strategies for coping. This should be a multidisciplinary effort including obstetricians, GPs, and psychiatrists. Pregnancy counseling should include a discussion of a treatment plan for the mother and the child, and monitoring for signs of deterioration, and, if needed adjustments to the medication regimen.